A method for individualizing the prediction of immunogenicity of protein vaccines and biologic therapeutics: individualized T cell epitope measure (iTEM).
about
Application of IgG-derived natural Treg epitopes (IgG Tregitopes) to antigen-specific tolerance induction in a murine model of type 1 diabetesBeyond humanization and de-immunization: tolerization as a method for reducing the immunogenicity of biologicsCoupling sensitive in vitro and in silico techniques to assess cross-reactive CD4(+) T cells against the swine-origin H1N1 influenza virus.Human immune responses to H. pylori HLA Class II epitopes identified by immunoinformatic methods.Integrated assessment of predicted MHC binding and cross-conservation with self reveals patterns of viral camouflagePoor correlation between T-cell activation assays and HLA-DR binding prediction algorithms in an immunogenic fragment of Pseudomonas exotoxin A.Challenges and opportunities in absorption, distribution, metabolism, and excretion studies of therapeutic biologics.Time for T? Immunoinformatics addresses vaccine design for neglected tropical and emerging infectious diseasesAntidotes, antibody-mediated immunity and the future of pharmaceutical product development.Preclinical development of HIvax: Human survivin highly immunogenic vaccinesDana-Farber repository for machine learning in immunology.Modulation of CD8+ T cell responses to AAV vectors with IgG-derived MHC class II epitopesImmunogenicity of Therapeutic Fusion Proteins: Contributory Factors and Clinical Experience
P2860
Q24627149-50CAE8BD-2038-41B9-8ABF-00DF699C9D73Q26826924-5CA814F0-7935-4AA5-A398-DA6DF052B7D4Q30400133-569F6964-A178-4A0D-A682-90AE4C93EB9EQ35150416-E8A51B73-F7B0-4BE9-9B3C-252305DE1243Q35221584-115A8F38-CCD6-4877-9D35-9420BDC8706FQ36157120-1DDCB5F4-3ED4-4CA0-B9A0-D3B596D13E93Q36331497-48BCBC9F-2214-4498-A961-E5A35FBE03CDQ36550981-FCA5EBAB-B03E-45E2-9786-608E2A792911Q38071898-1490799A-D475-49AB-8731-04AF0A2FA13FQ38867680-F7B35DBD-E336-4F13-AB36-02916FA9FD99Q40086895-4B676899-8259-49D6-A4D7-0BE09B72EC09Q41907025-0C88333B-BA55-4139-B6CD-38E5919F4FA8Q57537530-393F0AFE-D7FB-4D1E-BC21-A707AD2567A9
P2860
A method for individualizing the prediction of immunogenicity of protein vaccines and biologic therapeutics: individualized T cell epitope measure (iTEM).
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
A method for individualizing t ...... T cell epitope measure (iTEM).
@en
type
label
A method for individualizing t ...... T cell epitope measure (iTEM).
@en
prefLabel
A method for individualizing t ...... T cell epitope measure (iTEM).
@en
P2860
P50
P356
P1476
A method for individualizing t ...... T cell epitope measure (iTEM).
@en
P2093
Matthew Ardito
William Martin
P2860
P356
10.1155/2010/961752
P577
2010-07-18T00:00:00Z